21 results
F-1
BPTSY
Biophytis S.A.
4 Aug 23
Registration statement (foreign)
4:18pm
with this demographic shift, are expected to rise proportionally, as effective treatment options are currently lacking. We believe that developing
6-K
EX-10.2
BPTSY
Biophytis S.A.
21 Jul 23
Biophytis Announces $3.8 Million
6:01am
-Related Data. All statistical, demographic and market-related data included in or incorporated by reference in the Registration Statement
424B5
BPTSY
Biophytis S.A.
20 Jul 23
Prospectus supplement for primary offering
5:27pm
, including costs associated with treatments and long-term care for age-related diseases associated with this demographic shift, are expected to rise … , healthcare costs, including costs associated with treatments and long-term care for age-related diseases associated with this demographic shift
F-3
BPTSY
Biophytis S.A.
21 Apr 23
Shelf registration (foreign)
4:16pm
with this demographic shift, are expected to rise proportionally, as effective treatment options are currently lacking. We believe that developing treatments
20-F/A
en7zz 954rauduwyh4a
28 Oct 21
Annual report (foreign) (amended)
5:16pm
20-F
75osmq 49suy4c
12 Mar 21
Annual report (foreign)
2:38pm
424B4
fxn51l1gb4lzj2c3qocs
11 Feb 21
Prospectus supplement with pricing info
12:00am
F-1/A
qovfza
4 Feb 21
Registration statement (foreign) (amended)
2:42pm
F-1/A
8gv0ck
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1
4t3l2
19 Jan 21
Registration statement (foreign)
5:05pm
DRS/A
sj5a4 pt6d7d
23 Dec 20
Draft registration statement (amended)
12:00am
DRS
ef5f271mqt vxhyj4
20 Nov 20
Draft registration statement
12:00am
F-1/A
al2z vep9xt
11 Jul 19
Registration statement (foreign) (amended)
5:32pm
F-1/A
okmi z5sip00x
8 Jul 19
Registration statement (foreign) (amended)
5:15pm
F-1/A
uh6za
24 Jun 19
Registration statement (foreign) (amended)
4:31pm
F-1/A
1d2oup2t k5lf2
12 Jun 19
Registration statement (foreign) (amended)
5:19pm
F-1
em4a5xt
21 May 19
Registration statement (foreign)
9:06pm